Novel ABCA1 mutations in Tangier disease associated with early‐onset type 2 diabetes: A case report
Journal of Diabetes Investigation · 07.11.2026
DOI: 10.1111/jdi.70483 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Diabetes Investigation, online erschienen am 07.11.2026. Verfasst von Makoto Wada und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes, Metabolism and Endocrinology, International University of Health and Welfare, Narita Hospital, 852 Hatakeda, Narita, Chiba, 2…. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Tangier disease (TD) is a rare disorder caused by mutations in the ATP‐binding cassette transporter A1 (ABCA1) gene with autosomal recessive inheritance and is characterized by extremely low high‐density lipoprotein cholesterol (HDL‐C) and premature atherosclerosis. Although experimental studies suggest that ABCA1 plays an important role in pancreatic β ‐cell cholesterol homeostasis, its clinical contribution to diabetes development in humans remains unclear. We report a 69‐year‐old Japanese man with early‐onset type 2 diabetes mellitus, profound hypo‐HDL cholesterolemia (HDL‐C 5 mg/dL), and severe atherosclerotic cardiovascular disease. Genetic analysis identified compound heterozygous ABCA1 variants (p.Arg104Cys and the novel p.Asp1706Tyr), both of which were predicted to be potentially pathogenic, although direct functional validation was not performed. Despite a 40‐year duration of diabetes, endogenous insulin secretion was partially preserved. This case highlights phenotypic variability in TD and suggests that variant‐specific effects on ABCA1 function and polygenic susceptibility may influence diabetes development in humans.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Diabetes, Metabolism and Endocrinology, International University of Health and Welfare, Narita Hospital, 852 Hatakeda, Narita, Chiba, 286-8520, Japan.
- Center for Genetic Diagnosis, International University of Health and Welfare, Narita Hospital, 4-3, Kozunomori, Narita, Chiba, 286-8520, Japan.
- Institute of Medical Genomics, International University of Health and Welfare, 4-3, Kozunomori, Narita, Chiba, 286-8686, Japan.
- Department of Endocrinology, Hematology and Gerontology, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chiba, 260-8670, Japan.
- Center for Advanced Medicine, Chiba University Hospital, 1-8-1 Inohana, Chiba, 260-8670, Japan.
- Department of Diabetes, Metabolism and Endocrinology, School of Medicine, International University of Health and Welfare, 4-3, Kozunomori, Narita, Chiba, 286-8686, Japan.
ORCID-Profile: Masayuki Kuroda, Tomohiko Yoshida, Shoji Tsuji, Minoru Takemoto
Zitieren
APA
Wada, M., Saito-Sato, N., Tanaka, M., Nomoto, J., Watanabe, A., Kuroda, M., Maezawa, Y., Sato, T., Yagyu, Y., Toriumi, S., Kajiyama, A., Hashimoto, T., Ohtake, N., Yamaga, M., Yoshida, T., Tsuji, S., & Takemoto, M. (2026). Novel ABCA1 mutations in Tangier disease associated with early‐onset type 2 diabetes: A case report. Journal of Diabetes Investigation. https://doi.org/10.1111/jdi.70483
Vancouver
Wada M, Saito-Sato N, Tanaka M, Nomoto J, Watanabe A, Kuroda M, et al. Novel ABCA1 mutations in Tangier disease associated with early‐onset type 2 diabetes: A case report. Journal of Diabetes Investigation. 2026. doi:10.1111/jdi.70483
BibTeX
@article{Wada2026,
author = {Wada, Makoto and Saito-Sato, Naoko and Tanaka, Masaki and Nomoto, Junko and Watanabe, Aki and Kuroda, Masayuki and Maezawa, Yoshiro and Sato, Tetsuta and Yagyu, Yusuke and Toriumi, Shuji and Kajiyama, Amika and Hashimoto, Takahide and Ohtake, Naoki and Yamaga, Masaya and Yoshida, Tomohiko and Tsuji, Shoji and Takemoto, Minoru},
title = {Novel ABCA1 mutations in Tangier disease associated with early‐onset type 2 diabetes: A case report},
journal = {Journal of Diabetes Investigation},
year = {2026},
doi = {10.1111/jdi.70483}
}
EUVIMED